STEPHANIE H KIM

Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology SAINT LOUIS, MO NPI 1275914665

General Payments — all program years on this page

$3,686.79

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,809.54 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,468.2414
Travel and Lodging $341.303

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
BOSTON SCIENTIFIC CORPORATION $967.3410
Penumbra, Inc. $403.983
BARD PERIPHERAL VASCULAR, INC. $167.961
AngioDynamics, Inc. $154.041
Medtronic, Inc. $116.222

By program year

Program yearAmountRecords
2020 $24.001
2021 $1,217.3810
2022 $202.521
2023 $433.357
2024 $1,809.5417

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1076208452 Penumbra, Inc. $148.73 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1076208454 Penumbra, Inc. $116.14 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092569362 Boston Scientific Corporation $16.16 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092569364 Boston Scientific Corporation $27.17 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092569366 Boston Scientific Corporation $47.60 03/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092569368 Boston Scientific Corporation $48.12 03/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1092569370 Boston Scientific Corporation $77.68 03/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1092569372 Boston Scientific Corporation $105.16 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092569374 Boston Scientific Corporation $119.94 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092569376 Boston Scientific Corporation $144.32 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092569378 Boston Scientific Corporation $165.69 03/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092569380 Boston Scientific Corporation $215.50 03/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1095082006 AngioDynamics, Inc. $154.04 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1095782098 Penumbra, Inc. $139.11 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117141955 Medtronic, Inc. $15.21 03/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117141957 Medtronic, Inc. $101.01 03/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128480683 Bard Peripheral Vascular, Inc. $167.96 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.